Variable Interest Entity (Tables)

3 Months Ended

Dec. 31, 2018

Organization, Consolidation and Presentation of Financial Statements [Abstract]

The following assets and liabilities of Profarma are included in the Company's Consolidated Balance Sheets:



(in thousands)	December 31, 2018		September 30, 2018
Cash and cash equivalents	$	11,768	$	26,801
Accounts receivables, net	157,307		144,646
Merchandise inventories	172,153		168,931
Prepaid expenses and other	60,395		61,924
Property and equipment, net	33,567		32,667
Goodwill	82,309		82,309
Other intangible assets	79,482		80,974
Other long-term assets	9,111		8,912
Total assets	$	606,092	$	607,164

Accounts payable	$	145,413	$	150,102
Accrued expenses and other	58,611		37,195
Short-term debt	117,217		115,461
Long-term debt	44,885		39,704
Deferred income taxes	44,265		46,137
Other long-term liabilities	10,915		31,988
Total liabilities	$	421,306	$	420,587

- Definition

Tabular disclosure of the significant judgments and assumptions made in determining whether a variable interest (as defined) held by the entity requires the variable interest entity (VIE) (as defined) to be consolidated and (or) disclose information about its involvement with the VIE, individually or in aggregate (as applicable); the nature of restrictions, if any, on the consolidated VIE's assets and on the settlement of its liabilities reported by an entity in its statement of financial position, including the carrying amounts of such assets and liabilities; the nature of, and changes in, the risks associated with involvement in the VIE; how involvement with the VIE affects the entity's financial position, financial performance, and cash flows; the lack of recourse if creditors (or beneficial interest holders) of the consolidated VIE have no recourse to the general credit of the primary beneficiary (if applicable); the terms of arrangements, giving consideration to both explicit arrangements and implicit variable interests, if any, that could require the entity to provide financial support to the VIE, including events or circumstances that could expose the entity to a loss; the methodology used by the entity for determining whether or not it is the primary beneficiary of the variable interest entity; the significant factors considered and judgments made in determining that the power to direct the activities of a VIE that most significantly impact the VIE's economic performance are shared (as defined); the carrying amounts and classification of assets and liabilities of the VIE included in the statement of financial position; the entity's maximum exposure to loss, if any, as a result of its involvement with the VIE, including how the maximum exposure is determined and significant sources of the entity's exposure to the VIE; a comparison of the carrying amounts of the assets and liabilities and the entity's maximum exposure to loss; information about any liquidity arrangements, guarantees, and (or) other commitments by third parties that may affect the fair value or risk of the entity's variable interest in the VIE; whether or not the entity has provided financial support or other support (explicitly or implicitly) to the VIE that it was not previously contractually required to provide or whether the entity intends to provide that support, including the type and amount of the support and the primary reasons for providing the support; and supplemental information the entity determines necessary to provide.

+ References + Details